Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation (NASDAQ:TELA)
Earnings Name Insights: TELA Bio, Inc. (TELA) This fall 2025 Administration View Antony Koblish, Co-founder, CEO & Director, highlighted that ...
